Enrico Cipro Vanni
Direktor/Vorstandsmitglied bei ADVANCED ONCOTHERAPY PLC
Vermögen: 3 Mio $ am 31.08.2023
Aktive Positionen von Enrico Cipro Vanni
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADVANCED ONCOTHERAPY PLC | Direktor/Vorstandsmitglied | 01.10.2013 | - |
Independent Dir/Board Member | 01.10.2013 | - | |
Denzler & Partners | Direktor/Vorstandsmitglied | 14.09.2010 | - |
Banque Privée BCP (Suisse) SA
Banque Privée BCP (Suisse) SA Regional BanksFinance Banque Privée BCP SA provides private banking services to individual and institutional clients. It offers advisory, discretionary management, and execution services. The firm also offers deposits and other cash management, equity and equity funds, bonds and bond funds, commodities, and foreign exchange. The company is headquartered in Geneva, Switzerland. | Direktor/Vorstandsmitglied | 01.01.2009 | - |
Jan Autos Holding SA | Direktor/Vorstandsmitglied | - | - |
Lombard Odier & Cie (France) SA
Lombard Odier & Cie (France) SA Financial ConglomeratesFinance Part of Compagnie Lombard Odier SCmA, Lombard Odier & Cie (France) SA operates as a French investment company. The company is based in Paris, France. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Enrico Cipro Vanni
Ehemalige bekannte Positionen von Enrico Cipro Vanni
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Direktor/Vorstandsmitglied | 25.08.2011 | 01.01.2017 |
ALCON INC. | Direktor/Vorstandsmitglied | 13.09.2010 | 01.01.2011 |
Mckinsey & Co., Inc. (Switzerland) | Direktor/Vorstandsmitglied | 01.01.2007 | 01.01.2007 |
ALLERGAN PLC | Direktor/Vorstandsmitglied | 01.01.2010 | - |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Enrico Cipro Vanni
École Polytechnique Fédérale de Lausanne | Undergraduate Degree |
University of Lausanne | Doctorate Degree |
INSEAD | Masters Business Admin |
Statistik
International
Schweiz | 11 |
Frankreich | 3 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 11 |
Independent Dir/Board Member | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Finance | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ALCON INC. | Health Technology |
NOVARTIS AG | Health Technology |
ADVANCED ONCOTHERAPY PLC | Health Technology |
Private Unternehmen | 8 |
---|---|
Mckinsey & Co., Inc. (Switzerland) | |
Eclosion Foundation
Eclosion Foundation Investment Trusts/Mutual FundsMiscellaneous Eclosion Foundation offers researchers managerial and scientific support for their projects, from finance to validation resources. The firm also provides premises, laboratories, and services adapted to the needs of their clients. It focuses on biotechnology and biomedical engineering sectors. The company was founded by Jesús Martin-Garcia and Benoit Dubois and is headquartered in Plan-les-Ouates, Switzerland. | Miscellaneous |
Denzler & Partners | |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Finance |
Banque Privée BCP (Suisse) SA
Banque Privée BCP (Suisse) SA Regional BanksFinance Banque Privée BCP SA provides private banking services to individual and institutional clients. It offers advisory, discretionary management, and execution services. The firm also offers deposits and other cash management, equity and equity funds, bonds and bond funds, commodities, and foreign exchange. The company is headquartered in Geneva, Switzerland. | Finance |
Jan Autos Holding SA | |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Lombard Odier & Cie (France) SA
Lombard Odier & Cie (France) SA Financial ConglomeratesFinance Part of Compagnie Lombard Odier SCmA, Lombard Odier & Cie (France) SA operates as a French investment company. The company is based in Paris, France. | Finance |
- Börse
- Insiders
- Enrico Cipro Vanni
- Erfahrung